AJ Wealth Strategies’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$211K Hold
5,747
0.01% 277
2023
Q1
$234K Buy
5,747
+20
+0.3% +$864 0.01% 261
2022
Q4
$293K Hold
5,727
0.02% 235
2022
Q3
$251K Hold
5,727
0.01% 256
2022
Q2
$300K Hold
5,727
0.02% 240
2022
Q1
$296K Hold
5,727
0.01% 258
2021
Q4
$338K Hold
5,727
0.02% 237
2021
Q3
$246K Buy
5,727
+5
+0.1% +$222 0.01% 256
2021
Q2
$224K Hold
5,722
0.01% 252
2021
Q1
$207K Sell
5,722
-258
-4% -$9.16K 0.01% 245
2020
Q4
$220K Sell
5,980
-320
-5% -$11.7K 0.02% 219
2020
Q3
$219K Buy
+6,300
New +$221K 0.02% 199

Other funds holding PFE

AJ Wealth Strategies's PFE Position: Q2 2023 in Review

AJ Wealth Strategies held its Pfizer (PFE) position steady in Q2 2023 at 5,747 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #277.

AJ Wealth Strategies first reported a position in PFE in Q3 2020 and has held it in 12 quarters since. The position peaked at $338K in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • AJ Wealth Strategies held 5,747 shares of Pfizer worth $211K as of Q2 2023.
  • AJ Wealth Strategies left its Pfizer share count unchanged in Q2 2023.
  • Pfizer made up 0.01% of AJ Wealth Strategies's portfolio in Q2 2023, its #277 holding.
  • AJ Wealth Strategies first reported a position in Pfizer in Q3 2020 and has held it in 12 quarters since.
  • AJ Wealth Strategies's Pfizer position peaked at $338K in Q4 2021.
  • 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on AJ Wealth Strategies's 13F filing for Q2 2023, filed 20 Jul 2023.